Ikarian Capital »

Dex shares owned by Ikarian Capital

Quarter-by-quarter ownership of Dex (DXCM) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Dex

Tip: Access up to 7 years of quarterly data

All positions including Dex held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dex by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.1M 138k 66.37

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Dex

Vanguard Group
BlackRock
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Ubs Global Asset Management Americas
Citadel Advisors
Norges Bank Investment Management
Jpmorgan Chase & Co
Jennison Associates
Invesco
Amundi
Nuveen
Deutsche Bank Aktiengesellschaft
Goldman Sachs Group

View all funds holding Dex